1-6 of 6
Claire M. Lucas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PP2A Inhibition By CIP2A or SETBP1 Leads to Elevated Levels of AKT S473 Which Can be Used As a Biomarker of Outcome in Acute Myeloid Leukaemia

Robert K Hills, DPhil, Claire M Lucas, Laura J Scott, Natasha Carmell, Alison K Holcroft, Richard E. Clark, MD
Journal: Blood
Blood (2015) 126 (23): 1396.
https://doi.org/10.1182/blood.V126.23.1396.1396
Published: 2015
Journal Articles

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

Clinical Trials & Observations
Claire M. Lucas, Robert J. Harris, Athina Giannoudis, Mhairi Copland, Joseph R. Slupsky, Richard E. Clark
Journal: Blood
Blood (2011) 117 (24): 6660–6668.
https://doi.org/10.1182/blood-2010-08-304477
Published: 2011
Includes: Supplemental data
Journal Articles

Nilotinib concentration in Cell Lines and CML CD34+ Cells Is Not Mediated by Active Uptake or Efflux by Major Drug Transporters

Joanne Mountford, PhD, Andrea Davies, Niove E Jordanides, Athina Giannoudis, Claire M Lucas, Sophia Hatziieremia, Robert J Harris, Heather G Jorgensen, Munir Pirmohamed, Tessa L Holyoake, Richard E Clark
Journal: Blood
Blood (2008) 112 (11): 3205.
https://doi.org/10.1182/blood.V112.11.3205.3205
Published: 2008
Journal Articles

Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia

Athina Giannoudis, Andrea Davies, Claire M. Lucas, Robert J. Harris, Munir Pirmohamed, Richard E. Clark
Journal: Blood
Blood (2008) 112 (8): 3348–3354.
https://doi.org/10.1182/blood-2007-10-116236
Published: 2008
Journal Articles

Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells.

Andrea Davies, PhD, Athina Giannoudis, PhD, Claire M. Lucas, BSc, Robert J. Harris, PhD, Paul W. Manley, PhD, Munir Pirmohamed, PhD, FRCP, FRCP(E), Richard E. Clark, MA, MD, FRCP, FRCPat
Journal: Blood
Blood (2007) 110 (11): 2364.
https://doi.org/10.1182/blood.V110.11.2364.2364
Published: 2007
Journal Articles

Unlike Imatinib, Dasatinib Uptake into Chronic Myeloid Leukaemia Cells Is Independent of hOCT1 Expression.

Athina Giannoudis, PhD, Andrea Davies, PhD, Claire M. Lucas, BSc, Robert J. Harris, PhD, Munir Pirmohamed, PhD, FRCP, FRCP(E), Richard E. Clark, MA, MD, FRCP, FRCPat
Journal: Blood
Blood (2007) 110 (11): 3458.
https://doi.org/10.1182/blood.V110.11.3458.3458
Published: 2007